WHO ICTRP trial
A study to control the effectiveness of two drugs, which are phenobarbitone…
CTRI/2020/04/024952 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/04/024952 |
|---|---|
| Public title | A study to control the effectiveness of two drugs, which are phenobarbitone (used for seizures in first 28 days of life) and levetiracetam ( new drug for seizures) in newborns who have seizures in the first 24 hours of life with delayed cry at birth. |
| Scientific title | Efficacy of Levetiracetam versus Phenobarbitone in the control of neonatal seizures in asphyxiated newborns as first line therapy: a randomised controlled trial |
| Primary sponsor | Department of neonatology and pediatrics |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | India |
| Conditions | Health Condition 1: G998- Other specified disorders of nervous system in diseases classified elsewhere |
| Interventions | Intervention1: Comparing efficacy of levetiracetam and phenobarbitone in control of neonatal seizures due to perinatal asphyxia: Neonates will be loaded with IV levetiracetam in a dose of 40mg/kg diluted in 30ml of Normal saline infused… |
| Registration date | Apr 30, 2020 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: